Cumberland Pharmaceuticals (CPIX) Research & Development (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Research & Development for 16 consecutive years, with $1.5 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 19.88% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 15.58% year-over-year, with the annual reading at $5.6 million for FY2025, 15.58% up from the prior year.
- Research & Development hit $1.5 million in Q4 2025 for Cumberland Pharmaceuticals, up from $1.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.9 million in Q3 2023 to a low of $1.1 million in Q2 2024.
- Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $1.4 million in 2021.
- Biggest five-year swings in Research & Development: skyrocketed 38.79% in 2022 and later crashed 37.21% in 2023.
- Year by year, Research & Development stood at $1.6 million in 2021, then decreased by 12.83% to $1.4 million in 2022, then dropped by 10.04% to $1.3 million in 2023, then grew by 2.21% to $1.3 million in 2024, then rose by 19.88% to $1.5 million in 2025.
- Business Quant data shows Research & Development for CPIX at $1.5 million in Q4 2025, $1.3 million in Q3 2025, and $1.5 million in Q2 2025.